DIXON HUBARD FEINOUR & BROWN INC/VA - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIXON HUBARD FEINOUR & BROWN INC/VA ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2021$50,0000.0%19,6480.0%0.01%
-53.8%
Q4 2020$50,0000.0%19,6480.0%0.01%0.0%
Q3 2020$50,000
-15.3%
19,6480.0%0.01%
-13.3%
Q2 2020$59,000
+22.9%
19,6480.0%0.02%
-6.2%
Q1 2020$48,000
-48.4%
19,6480.0%0.02%
-33.3%
Q4 2019$93,000
+10.7%
19,6480.0%0.02%
+4.3%
Q3 2019$84,000
-27.0%
19,6480.0%0.02%
-30.3%
Q2 2019$115,000
+51.3%
19,6480.0%0.03%
+43.5%
Q1 2019$76,000
+105.4%
19,6480.0%0.02%
+64.3%
Q4 2018$37,000
-41.3%
19,6480.0%0.01%
-17.6%
Q3 2018$63,000
+6.8%
19,6480.0%0.02%0.0%
Q2 2018$59,000
-23.4%
19,6480.0%0.02%
-19.0%
Q1 2018$77,000
-4.9%
19,6480.0%0.02%
-4.5%
Q4 2017$81,000
-51.8%
19,648
-28.3%
0.02%
-54.2%
Q3 2017$168,000
-1.2%
27,3920.0%0.05%
-2.0%
Q2 2017$170,000
-2.3%
27,3920.0%0.05%
-5.8%
Q1 2017$174,000
+18.4%
27,3920.0%0.05%
+10.6%
Q4 2016$147,000
-4.5%
27,3920.0%0.05%
-2.1%
Q3 2016$154,000
-13.5%
27,392
-15.4%
0.05%
-15.8%
Q2 2016$178,000
-30.2%
32,3920.0%0.06%
-31.3%
Q1 2016$255,000
-5.2%
32,3920.0%0.08%
-3.5%
Q4 2015$269,000
-7.6%
32,392
+0.4%
0.09%
-19.6%
Q3 2015$291,000
+47.7%
32,276
+96.7%
0.11%
+75.4%
Q2 2015$197,00016,4100.06%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2018
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders